JAK/STAT and NOTCH1 pathway defects are often seen in T-cell malignancies (28) and may explain the distinction in B-cell and T-cell composition between the mpc-PTLD and FFH groups. The gene discussed is NOTCH1; the disease is post-transplant lymphoproliferative disease.